Loading data
RGENNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | 352.01 m USD | 359.79 m USD | 353.92 m USD | 345.83 m USD | 279.28 m USD |
| Research and development expense | 54.18 m USD | 43.2 m USD | 42.72 m USD | 43.94 m USD | 34.27 m USD |
| Selling, general and administrative expense | 290.51 m USD | 263.37 m USD | 218.58 m USD | 215.83 m USD | 183.87 m USD |
| Operating profit | 55.17 m USD | -35.11 m USD | 47.7 m USD | 224.67 m USD | 167.25 m USD |
| Interest expense | — | — | 1.95 m USD | 1.16 m USD | 11.28 m USD |
| Profit before tax | 62.38 m USD | -27.04 m USD | 56.71 m USD | 219.14 m USD | 153.54 m USD |
| Income tax expense | 13.49 m USD | -1.52 m USD | 21.11 m USD | 33.18 m USD | 25.25 m USD |
| Net income (reported basis) | 49 m USD | -26 m USD | 42 m USD | 186 m USD | 128 m USD |
| Basic earnings per share | 0.87 USD/share | -0.46 USD/share | 0.64 USD/share | 3.35 USD/share | 2.33 USD/share |
| Diluted earnings per share | 0.86 USD/share | -0.46 USD/share | 0.63 USD/share | 3.24 USD/share | 2.24 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.